BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Fred Frank, ‘Founding Father’ of Biotech, Dead at 89

  Frederick Frank, an innovator of biotech investment who played a key role in Roche’s acquisition of Genentech and the merger that formed Bristol-Myers Squibb, has died.

  September 13, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  AzurRx Carves Out Slice of IBD Market in $229 Million Buyout

  AzurRx will change its name to First Wave BioPharma, Inc., and the company’s shares will trade on the Nasdaq under the ticker symbol “FWBI.”

  September 13, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  AVITA’s Personalized Vaccine Kit Elicits Robust Immune Memory Response

  The Phase II study showed enhanced immune memory response to the virus in 96% of vaccinated subjects, all of whom were exposed to an environment dominated by the delta variant.

  September 13, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  BeiGene’s Immuno-oncology Portfolio Running Strong in Lung Cancer

  BeiGene plans to describe the power of its lung cancer portfolio at the European Society for Medical Oncology Congress 2021. The conference will run from September 16-21.

  September 13, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  A Recurring COVID-19 Origin Theory and a Vaccine for Kids by Halloween?

  Dr. Scott Gottlieb estimated that a vaccine for the 5-11-year-old age group could be available by Halloween – in a best-case scenario.

  September 13, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Pharm Country

  Survey Says Immunotherapy May be Effective for Early-Stage Cancer Treatment

  In a recent multinational survey, healthcare providers expressed the belief that immunotherapy will improve outcomes for patients with earlier-stage cancers.

  September 13, 2021

   · 

  4 min read

   · 

  BioSpace Editorial Staff
• 

  Business

  Industry Veteran Rusty Williams Leads Startup to $50 Million Series A

  South San Francisco-based Walking Fish started the week off strong by announcing its closing of a $50 million Series A financing round on Monday.

  September 13, 2021

   · 

  1 min read

   · 

  Ellen Bombela
• 

  Business

  AbbVie, REGENXBIO Partner on Potential One-Time Treatment for Wet AMD

  The drug, called RGX-314, is a possible one-time treatment for wet AMD, diabetic retinopathy, and other chronic retinal diseases.

  September 13, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Bolt’s Recent Collabs Support Goal of Pioneering New Class of Immuno-Oncology Agents

  Bolt Biotherapeutics was anything but quiet this summer.

  September 13, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Growing Glioblastomas in a Laboratory: 3D Bioprinting a Better Brain Model

  This newfound ability to take tumor cells directly from a patient and incorporate them into a more clinically accurate glioblastoma model could lead to greater patient personalization in cancer therapeutics.

  September 13, 2021

   · 

  5 min read

   · 

  Maggie Chen